Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE

HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM

Standard Dose
12.5MG;50MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 218015 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM Form and strength TABLET;ORAL - 12.5MG;50MG Sponsor GRANULES Submission history Latest submission status date: 2025-10-09 00:00:00.

Structured Monograph

Clinical summary

Approval overview LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 218015 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM Form and strength TABLET;ORAL - 12.5MG;50MG Sponsor GRANULES Submission history Latest submission status date: 2025-10-09 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM) | Drug Monograph | MedicHelpline